ClinicalTrials.Veeva

Menu

Testing Spread and Implementation of Novel Methicillin Resistant Staphylococcal Aureus (MRSA)-Reducing Practices

M

MaineHealth

Status

Completed

Conditions

MRSA Infections
Blood Stream Infections

Treatments

Behavioral: healthcare staff processes for infection prevention

Study type

Observational

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT01255943
HHSA290200600013

Details and patient eligibility

About

The purpose of this study is to implement strategies for improved efficiency and waste reduction ("Toyota Lean") and positive deviance, a social behavioral change process, utilizing frontline healthcare personnel to reduce infection bloodstream infection and MRSA infection in outpatient dialysis care. In two outpatient dialysis units, dialysis unit healthcare staff will be educated in Toyota lean techniques and conduct periodic "discovery and action" dialogues to identify and implement care process changes to reduce infection. Outcomes to be monitored will include incidence of bloodstream infections and MRSA infections of all types. Data will be assessed at quarterly intervals using interrupted time series analysis.

Enrollment

175 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: all hemodialysis patients at two outpatient dialysis units

Exclusion Criteria:peritoneal dialysis patients

Trial design

175 participants in 1 patient group

prevalent hemodialysis patients
Description:
These patients are observed in two outpatient dialysis units with a combined census of approximately 175 patients
Treatment:
Behavioral: healthcare staff processes for infection prevention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems